Strategies for neonatal hyperbilirubinemia: a literature review

Courtenay Wells1, Azza Ahmed, Anna Musser

  • 1Courtenay Wells is a Family Nurse Practitioner, Lafayette, IN. The author can be reached via e-mail at cwells@hotmail.com Azza Ahmed is an Assistant Professor, School of Nursing, Purdue University, IN. Anna Musser is a Pediatric Nurse Practitioner, Frankfort, IN.

Insights

Neonatal jaundice, a common condition, can cause severe hyperbilirubinemia and neurological damage. This article provides evidence-based guidelines for assessment, management, and treatment of infant jaundice.

Area of Science:

  • Neonatology
  • Pediatric Health
  • Clinical Nursing

Background:

  • Neonatal jaundice is common but can escalate to dangerous hyperbilirubinemia.
  • Severe hyperbilirubinemia poses risks of neurological damage and mortality in newborns.
  • Emerging technologies and research necessitate updated clinical approaches.

Purpose of the Study:

  • To outline evidence-based assessment techniques for neonatal hyperbilirubinemia.
  • To present current management guidelines and treatment options.
  • To clarify the nursing role in preventing and managing infant jaundice.

Main Methods:

  • Review of current literature on neonatal hyperbilirubinemia.
  • Analysis of evidence-based assessment and management strategies.
  • Discussion of nursing interventions and patient/family care.

Main Results:

  • Established protocols for assessing and managing neonatal jaundice.
  • Integration of new technologies and research findings into clinical practice.
  • Defined scope of nursing practice in neonatal hyperbilirubinemia care.

Conclusions:

  • Effective management of neonatal jaundice requires adherence to evidence-based guidelines.
  • Nurses play a crucial role in preventing complications and supporting affected families.
  • Continuous updates in technology and research are vital for optimal infant care.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
48
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Bronsted-Lowry Acids and Bases02:58

Bronsted-Lowry Acids and Bases

The acid-base reaction class has been studied for quite some time. In 1680, Robert Boyle reported traits of acid solutions that included their ability to dissolve many substances, to change the colors of certain natural dyes, and to lose these traits after coming in contact with alkali (base) solutions. In the eighteenth century, it was recognized that acids have a sour taste, react with limestone to liberate a gaseous substance (now known to be CO2), and interact with alkalis to form neutral...
78.2K